Projects (1337)

T1D-Plus: a clinical trial platform for combined beta cell preservation therapy  (01/09/2022  -  31/08/2026)

T1D-Plus: An adaptive trial platform for the study of combination therapies in new-onset T1D  (01/12/2023  -  30/11/2026)

T1D UK Clinical Trials consortium - mechanistic core  (01/01/2015  -  05/12/2021)

T1D UK Immunotherapy Consortium: Clinical Engagement and Training (CET) Core  (01/05/2015  -  30/03/2020)

Tackling epidemic threats byadvancing the science of humaninteractions and infection  (01/09/2024  -  31/05/2025)

Tackling Radicalisation in Dispersed Societies  (01/08/2012  -  31/07/2015)

TACTICC study  (01/06/2015  -  31/12/2016)

Taffs Well Thermal Spring - Heat recovery  (14/10/2019  -  30/03/2020)

Tai Ffres Research and Evaluation  (01/02/2023  -  31/07/2024)

Tailored OligoG in the treatment of chronic infectious biofilms  (27/11/2013  -  30/06/2017)

Tailored quantum structures  (01/06/2013  -  31/05/2015)

Taith Mobility Programme  (01/09/2022  -  31/08/2025)

Take home naloxone Intervention Multi centre Emergency setting feasibility trial (TIME)  (01/03/2018  -  31/08/2020)

Taking registered reports to the next level  (01/10/2020  -  30/09/2023)

Talking about HPV related cancer: Development and testing of scripted consultations  (01/07/2014  -  30/06/2016)

Talking changes: Developing best practice in co-producing well-being outcomes with looked-after children in Wales  (01/10/2017  -  27/06/2022)

Talking Trials: Exploration of clinical trial perceptions amongst BAME communities  (01/04/2020  -  31/03/2022)

Talking Trials: Participatory approaches to creating community dialogue  (01/10/2022  -  31/01/2024)

Talk Relationships Young Persons Participation Toolkit  (01/11/2024  -  28/02/2025)

Talybont Taste & Odour Event (summer 2024):Data review and research gaps  (16/01/2025  -  15/07/2025)

Tamil temple towns: Conservation and contestation  (14/02/2018  -  28/05/2023)

Tangible Interfaces for Assiting Young People with Neurodiversity Towards better Understanding Online Harms  (01/01/2024  -  31/12/2026)

Tanzanian Onshore Palaeogene Integrated Coring  (01/06/2014  -  31/05/2015)

TAP Centre  (01/01/2020  -  31/12/2022)

TAPERS study Excess Treatment Costs  (01/10/2018  -  31/01/2022)

Targeted drug delivery to the cornea of the eye via medicated contact lenses and mucoadhesive thin films  (01/02/2019  -  28/12/2022)

Targeted drug delivery to the cornea of the eye via thin-film slow release technology  (01/05/2017  -  31/08/2018)

Targeted metabolic inhibition of T-lymphocytes: Directing immunity during human disease  (01/10/2016  -  15/11/2018)

Targeted stabilisation of human cardiac ryanodine receptors as a therapeutic strategy for cardiac disease  (01/10/2009  -  30/09/2014)

Targeted vaccines for infectious disease and cancer  (01/04/2010  -  30/09/2010)

Targeted vaccines for infectious disease and cancer  (31/03/2010  -  30/09/2012)

Targeting alpha-beta - crystalline (CRYAB): A novel strategy to impede triple-negative breast cancer development  (01/07/2014  -  31/01/2016)

Targeting aquaporins function with organometallics: New tools in chemical biology and cancer therapeutics  (01/04/2017  -  30/04/2020)

Targeting cartilage regeneration in joint and intervertebral disc diseases  (01/03/2015  -  28/02/2019)

Targeting CD200 signalling to overcome cell carcinoma immune evasion  (01/01/2014  -  31/07/2017)

Targeting CD8 using “blocking anti CD8 antibodies” as a strategy to disable autoreactive CD8+ T-cells in Type 1 diabetes  (01/01/2023  -  29/02/2024)

Targeting CLL cell survival and proliferation with bioactive cell penetrating peptides  (01/10/2010  -  30/04/2014)

Targeting common mechanisms of pathogenesis in diseases of sterol homeostasis associated with lysosome dysfunction development of novel and rapidly translatable clinical therapies (STEROLOSOM)   (01/06/2012  -  31/05/2014)

Targeting complement to treat fatty liver disease  (01/10/2022  -  30/09/2025)

Targeting Coronaviruses through Fc-dependent Antibody Activities  (01/03/2025  -  29/02/2028)

Targeting CtIP to sensitise cancer cells to DNA-damaging agents  (01/11/2016  -  31/03/2018)

Targeting ERK signalling to ameliorate intellectual disability and autism spectrum disorder associated with chromosomal rearrangements at 16p11.2  (01/11/2019  -  31/10/2025)

Targeting ERK signalling to emeliorate intellectual disability and autism spectrum disorder associated with chromosomal rearrangements at 16p11.2  (01/11/2019  -  31/10/2025)

Targeting ERK signalling to emeliorate intellectual disability and autism spectrum disorder associated with chromosomal rearrangements at 16p11.2  (01/11/2019  -  31/10/2025)

Targeting glucose metabolism for the treatment of Birt Hogg Dube Syndrome  (01/10/2009  -  30/09/2010)

Targeting G-quadruplex nucleic acid structures with caffeine gold compounds for cancer treatment  (01/10/2016  -  22/12/2017)

Targeting islet-specific CD8 Tcells in Type 1 diabetes  (01/06/2015  -  31/01/2019)

Targeting long-term responses to chemotherapy through a novel stem/immune-related vulnerability in triple negative breast cancer  (23/03/2023  -  22/03/2026)

Targeting NAD+ for retinal ganglion cell protection in experimental glaucoma  (01/10/2019  -  30/12/2022)

Targeting natural products to counter the challenge of MRSA  (01/10/2014  -  30/09/2017)

Targeting neuroinflammation in mTORC1 driven brain tumours  (01/10/2019  -  31/05/2023)

Targeting neuroinflammation: Investigating disease mechanisms, and natural protective disease mechanisms to develop therapeutic interventions  (01/04/2025  -  31/03/2028)

Targeting NF-xB activation and proliferation signals in CLL  (01/11/2013  -  31/07/2018)

Targeting of interleukin-13 receptor (IL-13R) a2 expressing pancreatic cancer by a novel hybrid lytic peptide drug  (01/10/2016  -  15/11/2018)

Targeting Ref1/STAT3 to treat Tuberous Sclerosis  (01/04/2018  -  09/02/2023)

Targeting the allosteric control of alarmone synthetases to tackle bacteria persistence  (01/10/2017  -  15/01/2020)

Targeting the CD8 coreceptor as a novel strategy for the treatment of type 1 diabetes  (01/01/2013  -  31/12/2013)

Targeting the early endosome as a therapeutic strategy in neurodegenerative diseases  (01/01/2024  -  14/04/2027)

Targeting the pathological pathways to Parkinson's  (02/05/2018  -  01/08/2021)

Targeting the terminal pathway in complement - driven disease  (30/06/2018  -  30/09/2018)

Targeting the terminal pathway in complement-driven disease  (01/10/2016  -  30/09/2018)

Targeting the Wnt receptor frizzled-7 for the treatment of gastric cancer  (01/09/2018  -  31/08/2021)

Targeting tissue macrophage generation during inflammation as a mechanism to modulate the resolution of inflammation  (31/07/2012  -  30/07/2015)

Targeting Wnt signaling to treat metastatic prostate cancer  (01/09/2021  -  31/07/2025)

Targeting zinc signalling to prevent cell division in cancer  (01/10/2016  -  30/09/2018)

Targets for treatment in AML: discovery and translation  (20/09/2015  -  23/08/2019)

Targets for treatment in AML: Discovery and translation  (01/04/2010  -  19/09/2013)

Targets for treatment in AML: Discovery and translation  (20/09/2013  -  01/12/2015)

Target temperature management after cardiac arrest  (01/04/2011  -  31/12/2013)

Targetting zinc signalling to prevent cell division in cancer  (01/10/2015  -  30/09/2018)

Target validation and lead identification in osteoarthritis  (01/12/2011  -  30/11/2013)

Target validation, indication selection/prioritisation, review of pre-clinical validation efforts and overall strategy  (08/08/2016  -  18/09/2019)

Target validation laboratories suite in the Medicine Discovery Institute  (01/10/2019  -  31/10/2020)

Tarquinia  (01/04/2022  -  31/12/2022)

Task-related Training in Huntington's Disease: A home-based intervention study  (01/06/2012  -  01/05/2014)

Taste and Odour Predictive Modelling Project  (01/10/2020  -  30/09/2021)

Taster for clinicians  (10/08/2015  -  04/10/2015)

Taverns, locals and street corners: Cross chronological studies in community drinking, regulation and public space  (01/02/2012  -  31/01/2013)

TBI-REPORTER (UK-TBI REpository and data PORTal Enabling discoveRy)  (01/10/2023  -  30/09/2028)

T cell correlates of successful immunotherapy  (01/10/2015  -  30/09/2018)

T-cell correlates of successful immunotherapy  (01/10/2016  -  30/09/2020)

T cell cross-reactivity  (09/05/2018  -  18/02/2019)

T-cell cross-reactivity causes Type 1 diabetes  (01/07/2015  -  31/10/2016)

T cell receptor repertoire of insulin reactive CD8 T cells  (01/10/2011  -  30/09/2014)

T-cell receptors for cancer immunotherapy  (01/10/2012  -  30/09/2015)

T cells, monocytes and neutrophils: Detrimental crosstalk in peritoneal dialysis-related infection.  (01/04/2009  -  31/03/2013)

Teacher research project  (31/03/2018  -  31/03/2019)

Teacher research project  (31/03/2018  -  31/03/2019)

Teacher training incentives in Wales, incentives in other professions  (08/02/2019  -  24/05/2019)

Teaching and learning issues in the disciplines  (01/06/2015  -  31/07/2015)

Teaching and learning resource for social workers in Wales  (01/10/2009  -  31/08/2010)

Teaching early reading skills to adults with intellectual disabilities (READ-IT) using a support worker/family carer mediated on-line reading programme – a feasibility study  (01/09/2019  -  31/03/2022)

Technical and commercial feasibility projects  (01/04/2013  -  31/10/2014)

Technical experiments and investigations to generate mist and spray  (03/10/2013  -  23/11/2014)

Technical repair advisors for the grants for places of worship programme in Wales  (01/08/2013  -  31/03/2017)

Techniques for supporting biodiversity informatics research  (01/10/2005  -  30/09/2009)

Techno-Economic Assessment of Caerphilly Hydrogen Hub  (19/01/2023  -  30/06/2023)

Technology development towards sustainable marine current energy harvesting for coastal communities in Mexico  (24/02/2020  -  17/03/2023)